Literature DB >> 17642747

Seroprevalence of herpes simplex virus-1 and 2 antibodies in STD clinic patients.

A Aggarwal1, R Kaur.   

Abstract

The present study was conducted on 250 serum samples of STD clinic patients and 50 serum samples of asymptomatic women to determine seroprevalence of herpes simplex-1 and 2 (HSV-1 and 2) IgM antibodies and HIV-1 and 2 antibodies. The samples were also screened for syphilis by VDRL test and confirmed by TPHA test. Seropositivity of HSV in STD clinic patients was 44/250 (17.6%) and 12/50 (24%) in asymptomatic women. In 11/44 (25%) seropositive persons for HSV, HIV 1 and 2 antibodies were present. In 10/44 (22.7%) HSV seropositive persons, coinfection with syphilis was also present, whereas in 7/44 (15.9%) HSV seropositive persons, both HIV and syphilis were present. In the control group, coinfection with other sexually transmitted infections (STIs) was not observed.

Entities:  

Year:  2004        PMID: 17642747

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  4 in total

1.  State of the Globe: Detecting HSV in Clinical Setting.

Authors:  Sheetal Vanjeri; Sagar Galwankar
Journal:  J Glob Infect Dis       Date:  2012-07

2.  Serum HSV-1 and 2 IgM in Sexually Transmitted Diseases - More for Screening Less for Diagnosis: An Evaluation of Clinical Manifestation.

Authors:  Dharmishtha G Tada; Nita Khandelwal
Journal:  J Glob Infect Dis       Date:  2012-07

3.  ToRCH-screening in pediatric cataract revisited: A North Indian tertiary care centre study.

Authors:  Sushobhan Dasgupta; Tarannum Shakeel; Reshmi Chanda Roy
Journal:  Indian J Ophthalmol       Date:  2020-05       Impact factor: 1.848

4.  Etiology of Vaginal/Cervical Discharge Syndrome: Analysis of Data from a Referral Laboratory in Eastern India.

Authors:  Ishita Ghosh; Bandhan Paul; Nibedita Das; Debabrata Bandyopadhyay; Manas Kumar Chakrabarti
Journal:  Indian J Dermatol       Date:  2018 Nov-Dec       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.